The Graft

The Graft

By The EBMT Trainee CommitteeMedicineHealth & Fitness
Download on the App Store

The Graft episodes

  • #17 Nihar Desai: India

    Final year hematology fellow: @nihardesai7


    Interview: Nico Gagelmann, Claire Horgan

    CONNECT WITH US 

    https://twitter.com/TheEBMT_Trainee

    https://www.ebmt.org/trainee-committee

    https://twitter.com/NicoGagelmann

    https://twitter.com/Claire_P_Horgan

    1 hr 2 min
  • #14 Sanam Loghavi: Hematopathology

    Assistant Professor, Department of Hematopathology, Division of  Pathology/Lab Medicine, The University of Texas MD Anderson Cancer  Center, Houston, TX

    Interview: Nico Gagelmann, Claire Horgan

    34 min
  • #13 Toby Eyre: CLL - past, present, future

    Dr Toby Eyre is a substantive consultant haematologist at Oxford  University Hospitals NHS Foundation Trust specialising in the management  of lymphoid malignancies. He is considered a national expert in the  management of patients with lymphoma and patients with chronic lymphocytic leukaemia. Twitter: https://twitter.com/TobyEyre82 Interview: Nico Gagelmann

    54 min
  • #12 Ruemu Birhiray: Access and diversity in medicine and research, ASH

    Dr. Birhiray earned a Doctor of Medicine degree from the University of  Benin, Nigeria, and completed his Internal Medicine residency at  Columbus Hospital (an affiliate of Northwestern University) in Chicago,  Illinois. He completed fellowships in Bone Marrow Transplant and Medical  Oncology at Johns Hopkins University and The National Cancer Institute  in Bethesda, Maryland, respectively. Dr. Birhiray has participated in  research and is published on the subjects of immunotherapy, lymphomas  and bone marrow transplantation. Dr. Birhiray is a member of The  American Society of Clinical Oncology, American Society of Hematology,  American Medical Association and the Wisconsin Medical Society.  Interview: Nico Gagelmann and Claire Horgan

    40 min
  • #11 Trainee realities in Latin America

    The following podcast hosts trainees from Latina America, Laura Saavedra  from Venezuela, Andres Gomez from Mexico, Rafaela Muratori from Brazil  and Susy Bazan from Peru. This recording is the second part, where we discuss shared experiences and challenges. But most of the time, we will listen to them and learn from them. The first part with presentations of each country can be found on our youtube channel: https://youtu.be/fJmv5glG1sY

    1 hr 12 min
  • #10 Nada Hamad: Access and diversity in training and healthcare, ANZTCT

    The following is a conversation with Prof Nada Hamad, a senior staff specialist in bone marrow transplant, clinical and laboratory haematologist at St Vincent’s hospital in Sydney, where she is also director of the haematology clinical trials unit. She is President of the Bone Marrow Transplant Society of Australia and New Zealand. She is a senior lecturer at the University of Sydney and University of NSW.

    58 min
  • #9 Vincent Rajkumar: myeloma, COVID, drug costs, mistakes, training

    The following is a conversation with Prof Vincent Rajkumar is engaged in  clinical, epidemiological and laboratory research in myeloma and  related disorders. Dr. Rajkumar served as the principal investigator on  several clinical trials for the treatment of myeloma. We talk with him  about myeloma, COVID, how he thinks trainees can make sense of all the  data out there, access to treatments and drug costs.

    Interview: Nico Gagelmann, Claire Horgan

    1 hr 7 min
  • #8 Chris Lewis: cancer, discrimination, COVID, death, communication

    This conversation is about cancer and all the overwhelming challenges  and potential discrimination that come with the diagnosis, inequalities,  death, the impact of COVID, the importance of time and communication,  and Chris' unique and inspiring story.

    His website: www.chris-cancercommunity.com

    SimPal: https://www.yoursimpal.com/

    Interview: Nico Gagelmann

    1 hr 19 min

About The Graft

From the publisher's feed

Conversations about stem cell transplant, cellular therapy, blood cancers, medicine, education, science, research, burden of disease, and humanity.